insights_auto
Why is TCRX down 4,40%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
0,16 $
arrow_downward
-4,40%(-0,0074) 1D
13 қар., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
0,17 $
High
0,17 $
Low
0,16 $
Mkt. cap
10,76 млн
Avg. vol.
547,00 м.
Volume
15,00
52-wk high
1,47 $
52-wk low
0,16 $
EPS
-0,89 $
Beta
1,21
Shares outstanding
63,50 млн
No. of employees
43
Open
0,17 $
High
0,17 $
Low
0,16 $
Mkt. cap
10,76 млн
Avg. vol.
547,00 м.
Volume
15,00
52-wk high
1,47 $
52-wk low
0,16 $
EPS
-0,89 $
Beta
1,21
Shares outstanding
63,50 млн
No. of employees
43
News stories
From web sources and news partners
Quantisnow
·
22 минут бұрын
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Record Q3 Revenue, Up...
ChartMill
·
24 минут бұрын
Steel Dynamics (NASDAQ:STLD): A GARP Case for Growth at a Reasonable Price
Investing.com
·
20 минут бұрын
Modern Mining converts $4.3M debt into equity after NYSE debut
The Washington Post
·
21 минут бұрын
Nearly a fifth of the S&P 500 is tied to three men with no clear successors
About Tscan Therapeutics Inc
CEO-
Employees43
Founded2018
HeadquartersWaltham, Массачусетс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitetscan.com